Our Mission

• To rapidly develop a set of drugs to cure cancer without serious side effects
• To make the drugs affordable to all cancer patients

Organizational Structure

The Cure Cancer Project is a Delaware nonprofit corporation, which will file for 501(c)(3) nonprofit status. The Cure Cancer Project does not yet have IRS tax exempt status. However, tax deductible donations to support the formation of the Cure Cancer Project can be made through the Partnerships for Cures, which is an IRS approved public charity and which will administer the funds during the formative stages of the organization.

Prominent Supporters

A number of leading scientists and physicians have strongly endorsed The Cure Cancer Project in a recent editorial published on the web by the Van Andel Research Institute. Click here for more information and to read the editorial.

Legal Representation

Sarah E. Paul from the law firm of Holland + Knight is counsel to the Cure Cancer Project.

Board of Directors

The leadership of the Cure Cancer Project is in the process of being determined. CCP will seek nationally respected leaders from the business and scientific community and individuals who are passionate about the cure of cancer to serve as Board members.

Management

The C.E.O. of the Cure Cancer Project will be an individual with demonstrated success in building and managing a large, complex, innovative engineering project. 

Funding

The Cure Cancer Project plans to raise approximately $150 million dollars in charitable donations from individuals, foundations and industry to fund the pre-clinical development work.

Disclosure Statement

The technology of pattern recognition tumor targeting was developed by Drug Innovation and Design, Inc. (DIAD)* and is the subject of pending patents. The Cure Cancer Project will need to enter into  licensing agreements with DIAD (as well as other companies and institutions) to fulfill its mission. All such agreements will be transparent, negotiated by an independent board of directors and in accord with the highest ethical and legal standards. At the present time no such licensing agreements exist.